U.S. Other Utilities Stock News

NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

DLocal (DLO) Is Up 11.9% After Unveiling New Dividend Plan And Reporting 23% Revenue Growth

In the past year, payment technology company DLocal announced that revenue rose 23% to US$960 million and EBITDA increased 24% to US$203 million, alongside expanding into Africa through its AZA Finance acquisition and declaring plans to distribute 30% of free cash flow as dividends from 2026. Together with recent earnings beats and upgrades to Buy ratings from Goldman Sachs and Truist Securities, these moves highlight how DLocal is pairing growth investment with a new commitment to returning...
NYSE:GBX
NYSE:GBXMachinery

A Look At Greenbrier Companies (GBX) Valuation As Weak Demand And Cash Flow Concerns Pressure The Story

Recent commentary on Greenbrier Companies (GBX) has focused on two years of declining unit sales, tighter supply chain competition, high production costs that have compressed gross margins to 14%, and negative free cash flow that has heightened investor scrutiny. See our latest analysis for Greenbrier Companies. Against those headwinds, the share price has shown strong momentum, with a 16.21% 1 month share price return, a 36.01% 3 month share price return, and a 106.10% 3 year total...
NYSE:AGM
NYSE:AGMDiversified Financial

Is Federal Agricultural Mortgage (AGM) Attractive After A 26% One-Year Share Price Slide

If you are wondering whether Federal Agricultural Mortgage is starting to look like value after its recent pullback, this article will walk through what the current share price might be implying about the company. The stock last closed at US$149.46, with a 14.1% decline over 7 days, a 12.7% decline over 30 days, a 15.3% decline year to date, and a 25.8% decline over the past year, while the 3 year and 5 year returns sit at 15.9% and 103.1% respectively. Recent coverage has focused on how...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Assessing Victoria's Secret (VSCO) Valuation After Strong Q3 Beat And Upgraded Full Year Outlook

What sparked the latest move in Victoria's Secret (VSCO)? Victoria's Secret (VSCO) shares have been in focus after the retailer reported third quarter results that topped sales and earnings expectations and raised its full year outlook, citing ongoing business momentum. See our latest analysis for Victoria's Secret. The latest earnings beat and upgraded outlook come on top of a sharp improvement in recent trading, with a 90 day share price return of 75.54% and a 1 year total shareholder...
NYSE:LC
NYSE:LCConsumer Finance

Do Insider Sales Clash With LendingClub’s Marketplace Banking Momentum And What It Means For LC?

On February 17, 2026, LendingClub’s Chief Risk Officer Annie Armstrong sold 5,333 shares, adding to a year of consistent insider selling activity. At the same time, LendingClub’s marketplace banking model has supported very strong five-year annual revenue growth and rapidly expanding earnings per share. We’ll now examine how this combination of robust earnings momentum and ongoing insider share sales influences LendingClub’s investment narrative. Capitalize on the AI infrastructure...
NasdaqCM:IMNM
NasdaqCM:IMNMBiotechs

Assessing Immunome (IMNM) Valuation After Recent Share Price Pullback

What recent performance says about Immunome (IMNM) Immunome (IMNM) has been on many biotech watchlists after a mixed stretch in its share price, with a decline over the past month but a gain across the past 3 months and strong 1 year and 3 year total returns. See our latest analysis for Immunome. Short term, the 30 day share price return of 16.89% decline and recent weekly softness suggest fading momentum. However, the 1 year and 3 year total shareholder returns remain very strong compared...
NYSE:KSS
NYSE:KSSMultiline Retail

A Look At Kohl's (KSS) Valuation After Recent Share Price Weakness

Kohl's (KSS) is back in focus after recent trading left the share price at US$18.78, with a 1-day return of a 2.49% decline and a 7-day return of a 5.39% decline. See our latest analysis for Kohl's. While the recent 7 day share price return of a 5.39% decline, alongside a 1 day drop and year to date weakness, points to fading short term momentum, the 90 day share price return of 19.39% and 1 year total shareholder return of 62.92% show a very different longer term picture that investors are...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Why Reddit (RDDT) Is Up 7.5% After Surging Revenue And User Growth Beat Analyst Expectations – And What's Next

In recent days, Reddit reported revenue growth of 69.7% year on year, surpassing analyst forecasts by 8.7% and lifting daily active users to 52.5 million, while leadership outlined a focus on sharper execution, global expansion, and product innovation rooted in real conversations. This combination of stronger-than-expected financial performance and expanding user engagement highlights how Reddit’s community-driven model is being translated into a more scalable, monetizable platform for...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

CSX Safety Questions And Corridor Sale Reshape Rail Risk And Returns

CSX (NasdaqGS:CSX) freight train derailed in Chicago's south suburbs, with 17 cars leaving the tracks and triggering a federal investigation by the FRA and NTSB. No injuries or hazardous material spills were reported, but the incident caused transportation disruptions and renewed attention on rail safety and operations. Separately, St. Petersburg approved the purchase of a CSX rail corridor to convert into a public trail, reflecting ongoing reuse of freight infrastructure for community...
NYSE:GEV
NYSE:GEVElectrical

Assessing GE Vernova (GEV) Valuation After Strong Recent Shareholder Returns

GE Vernova at a Glance: What Recent Returns Signal for Investors GE Vernova (GEV) has drawn increased investor attention after a recent share price move, with the stock showing a 0.5% decline over the past day but gains over the week, month, and past 3 months. Those returns sit alongside reported annual revenue of US$38.1b and net income of US$4.9b, giving investors a sense of the company’s current earnings base as they assess whether recent price action aligns with fundamentals. See our...
NYSE:FIG
NYSE:FIGSoftware

Figma Leans Into AI Credits And Partnerships To Deepen Product Influence

Figma (NYSE:FIG) is introducing AI credit subscriptions with monthly usage limits for its AI tools starting in March. The company announced new partnerships with ServiceNow and deeper collaborations with Anthropic and OpenAI. Figma launched a new Code to Canvas feature that turns AI generated code directly into design components inside its platform. Figma, best known for its cloud based design platform, is pushing further into AI at the same time many software companies are rethinking how...
NYSE:A
NYSE:ALife Sciences

FDA Approval Deepens Agilent Role In KEYTRUDA Ovarian Cancer Testing

Agilent Technologies (NYSE:A) received FDA approval for its PD-L1 IHC 22C3 pharmDx test as the only FDA approved companion diagnostic for certain ovarian, fallopian tube, and primary peritoneal carcinoma patients. The approval supports identification of patients who may be eligible for treatment with KEYTRUDA therapy. For Agilent Technologies, this decision sits at the core of its diagnostics and precision medicine business, where companion tests help match patients with specific therapies...
NasdaqGS:FISV
NasdaqGS:FISVDiversified Financial

Evaluating Fiserv (FISV) After A Steep 1 Year Shareholder Return Loss

Intro Fiserv (FISV) has drawn investor attention after a stretch of mixed share performance, with a negative 1 year total return and share price around $61.47. This has prompted fresh interest in how its payments and financial technology profile stacks up today. See our latest analysis for Fiserv. Recent trading has been choppy for Fiserv, with a 7 day share price return of 3.55% but a 30 day share price decline of 9.01%. The 1 year total shareholder return sits at a steep 73.51% loss,...
NYSE:WELL
NYSE:WELLHealth Care REITs

Is It Too Late To Consider Welltower (WELL) After A 43% One Year Surge?

Many investors are asking whether Welltower's current share price is aligned with its underlying value, or whether expectations have moved ahead of the fundamentals. The stock last closed at US$208.19, with a 1 year return of 42.6% and a 3 year return that is very large at around triple the starting point. This kind of performance can change how the market views both its growth potential and its risk profile. Recent headlines around Welltower have focused on portfolio activity, capital...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Viking Therapeutics (VKTX) Valuation In Focus As VK2735 Advances In GLP 1 Weight Loss Trials

Viking Therapeutics (VKTX) is back in focus after reporting a full year 2025 net loss of US$359.64 million and a wider basic loss per share, while advancing weight loss candidate VK2735 through late stage trials. See our latest analysis for Viking Therapeutics. At a share price of US$31.03, Viking Therapeutics has a 7 day share price return of 7.00%, while the 90 day share price return of 12.49% and year to date share price return of 12.39% suggest momentum has cooled compared with its very...
NYSE:PRKS
NYSE:PRKSHospitality

A Look At United Parks & Resorts (PRKS) Valuation Following Its Recent Rebrand

United Parks & Resorts stock: event-driven snapshot United Parks & Resorts (PRKS) has been drawing attention after its recent rebrand from SeaWorld Entertainment, with investors reassessing the theme park operator’s US$35.44 share price along with its mixed short and longer term return profile. See our latest analysis for United Parks & Resorts. Recent trading has been choppy, with a 7 day share price return of 4.36%, a 30 day share price return of 5.47%, and a 1 year total shareholder return...
NYSE:ABBV
NYSE:ABBVBiotechs

AbbVie’s New CLL Regimen And US$380 Million Facilities Shift Narrative

AbbVie (NYSE:ABBV) received FDA approval for its all oral, fixed duration VENCLEXTA and acalabrutinib regimen for previously untreated chronic lymphocytic leukemia. The new combination represents AbbVie's first all oral fixed duration treatment in this front line setting. The company announced a US$380 million investment to build advanced pharmaceutical manufacturing facilities using automation and AI in the United States. The manufacturing build out is intended to support growth in AbbVie's...
NYSE:GE
NYSE:GEAerospace & Defense

General Electric (GE) Is Up 8.8% After New Aerospace Engine Wins And Space Deals - Has The Bull Case Changed?

In recent weeks, Starfighters Space moved its STARLAUNCH 1 rocket program into Critical Design Review with engineering support from GE Aerospace, while United Airlines announced it selected 300 GEnx engines from GE Aerospace to power its expanded Boeing 787 Dreamliner fleet. Together with a new U.S. Air Force engine development contract and other aerospace collaborations, these developments highlight GE Aerospace’s expanding role across commercial, defense, and emerging space propulsion...
NYSE:GXO
NYSE:GXOLogistics

Is It Too Late To Consider GXO Logistics (GXO) After Its 67% One Year Rally?

Wondering if GXO Logistics is still good value after its recent run, or if you might be late to the story? This article is aimed squarely at that question. The share price recently closed at US$65.59, with returns of 0.1% over 7 days, 14.2% over 30 days, 20.8% year to date, and 66.9% over the past year. These figures naturally raise questions about growth potential and changing risk perceptions. Recent coverage has focused on GXO Logistics' position in outsourced logistics and warehouse...
NYSE:UHS
NYSE:UHSHealthcare

Universal Health Services Earnings Beat Highlights Valuation Gap And Outlook Shift

Universal Health Services (NYSE:UHS) reported quarterly earnings that surpassed Wall Street expectations. Results were supported by a recent Medicaid reimbursement and steady demand across its facilities. Management raised its revenue outlook for 2025 following the reimbursement and stronger operating trends. For investors watching NYSE:UHS, the latest update comes with the stock trading around $230.49 and a 1 year return of 28.6%. Over 3 years the stock has returned 59.1%, and over 5 years...
NasdaqGS:VIAV
NasdaqGS:VIAVCommunications

The Bull Case For Viavi Solutions (VIAV) Could Change Following ePRTC360+ Timing Security Launch - Learn Why

Earlier this week, Viavi Solutions unveiled its Mobile World Congress 2026 lineup and the new Cesium-less ePRTC360+ holdover clock, highlighting advances in network testing, quantum-safe communications, AIOps, AI data centers, and resilient GNSS-denied timing for critical infrastructure. The ePRTC360+ solution, positioned as an affordable alternative to Cesium clocks and designed for easy integration across networks, underscores Viavi’s push into timing security for power grids, aviation,...
NYSE:CVNA
NYSE:CVNASpecialty Retail

How Investors Are Reacting To Carvana (CVNA) Rising Revenue, Higher Costs, And A $1.23 Billion Equity Raise

In February 2026, Carvana reported past fourth-quarter 2025 results showing revenue rising to US$5.60 billion and net income to US$857 million, but profit metrics and margins came in below some expectations due to higher vehicle reconditioning costs. On the same day, Carvana also completed about US$1.23 billion in follow-on equity offerings, strengthening its balance sheet just as investors are weighing higher costs, mixed profitability, and questions raised by short sellers over...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

A Look At Exelixis (EXEL) Valuation As Shares Trade Near Narrative Fair Value Estimate

What Exelixis Stock’s Recent Moves May Be Telling Investors Exelixis (EXEL) has been relatively steady overall, with a small 1 day decline of about 1.2% and a 7 day move of roughly 0.7% lower, while the past 3 months show a gain near 3.3%. See our latest analysis for Exelixis. At a share price of US$43.63, Exelixis has seen short term share price momentum soften, yet its 1 year total shareholder return of about 18.4% and 3 year total shareholder return of roughly 1.5x suggest longer term...
NasdaqCM:BULL
NasdaqCM:BULLCapital Markets

Assessing Webull (BULL) Valuation After Steep Share Price And Revenue Losses

Why Webull Is Drawing Investor Attention Now Webull (BULL) has been attracting attention after posting annual revenue of about US$514.8m alongside a net loss of roughly US$524.7m, prompting investors to reassess how its digital brokerage model is being valued. See our latest analysis for Webull. Webull’s latest results come after a sharp shift in sentiment, with a 30 day share price return of 24.62% decline and a 1 year total shareholder return of 49.28% loss suggesting momentum has been...